Residency Listing

Sentara Healthcare Hampton Roads
600 Gresham Drive
Pharmacy Administration
Norfolk, VA 23507
Code: 38500
NMS Code: 114013
Postgraduate Year One (PGY1)
Accreditation Status: Accredited
Residency Program Director: Neil A. Davis, Pharm.D.
(757) 395-3349
Fax: (757) 395-8758
Director of Pharmacy: Christopher D. Tagliente, Pharm.D., BCPS
(757) 388-4020
Fax: (757) 388-4018
Residency Information:
Duration/Type: 12 mo. residency
Number of Positions: 4
Application Deadline: 1/9/2019
Starting Date: 7/1/2019
Estimated Stipend: 41000
Interview Required: Yes
Residency Special Features:   PGY-1 residency in the #2 integrated healthcare system in the country, with rotations available in 7 hospitals and an HMO. The largest hospital, Sentara Norfolk General, is a 600-bed teaching/community tertiary medical center with opportunities ranging from organ transplantation to Level 1 trauma care. The pharmacy department overseen by a single pharmacy director participates in standardized/organized utilization management/formulary programs. Rotations are available in medical/surgical/cardiac ICU, adult medicine/surgery, ambulatory care, neonatal care, infectious diseases, cardiology, oncology, nutrition, psychiatry, pharmacy benefit management, and health system pharmacy administration.
Fringe Benefits:   Health/life insurance, ASHP Midyear attendance, 2 weeks vacation leave
Special Requirements for Acceptance:   Three letters of recommendation, academic transcript, curriculum vitae, VA license within 1 month of starting.
Training Site Type: Hospital Managed Care, Homecare, Longterm care, Ambulatory care
Owner Affiliate: Sentara Healthcare
Model Type(s): Tertiary, teaching, community health system
Tax Status: Nonprofit
Professional Staff: 100
Non-Professional Staff: 100
Number of Medical Centers: 6
Total Beds: 1700
Average Daily Census: 1100
Site Special Features:   Located in Virginia Beach/Norfolk within minutes of the Chesapeake Bay and the Atlantic Ocean. Areas of research in pharmacy department are in medication safety, drug surveillance programs, and community health initiatives.